Healthtech set to continue its strong growth trajectory as we come out of lockdown, says leading Manager of healthtech ETF
patients expected to grow 3 fold from 2019 to 64 million in 2023
A spokesperson from the HAN-GINS
Indxx Health ETF (WELL) says Healthcare Cloud
spending has enabled Telemedicine to flourish during the Covid-19 crisis, and
this will expand further as we return to normal because of its huge
‘convenience’ factor. Evidence of this
includes the fact that many mainstream medical insurance plans now include
insurance for Telemedicine.
In the US this is predicted to lead to a trebling in the
number of telemedicine patients by 2023 to 64 million, from just 21 million in
2019. The annual growth rate in 2020 was
almost 100%.  ibid
The WELL health ETF also expects Gene Sequencing and Robotics players (Intuitive Surgical)
to enjoy significant growth as genomics become increasingly mainstream across
the medical field: robotic surgery leads
to less infections and reduced hospital stays.
Healthcare Trackers/Wearables are increasingly popular too – the ETF expects
Big Tech to become increasingly active in this space.
Anthony Ginsberg, Co-creator of HAN-GINS
Indxx Healthcare Innovation UCITS ETF (WELL), said: “The Covid-19 crisis is forcing healthcare
systems to innovate, fast-tracking digital health adoption rates. Cloud-based
hospital spending is enjoying a boom and enabling new health-tech products and
services. Gene Sequencing and Biotech areas
are seen as increasingly mainstream for healthcare solutions such as
“Remote Wearables/Trackers and Telemedicine are
experiencing a huge surge due to private and government insurance now covering
such procedures. Telemedicine is on
track to grow by over 30% annualised between 2021-2025.
HAN-GINS Indxx Health ETF (WELL) has
delivered a return of 35.48% over the past 12 months. Please remember that the value of your
investment may go down as well as up and past performance is no indication of
future performance. When you trade ETFs
your capital is at risk.
The WELL health
ETF is a UCITS compliant Exchange Traded Fund domiciled in Ireland. It
tracks the Indxx Advanced Life Sciences & Smart Healthcare Thematic Index
(Net Total Return), an index designed to measure the performance of large, mid
and small-capitalisation companies primarily listed on an exchange in Developed
and Emerging Markets that are involved in the Advanced Life Sciences &
Smart Healthcare sector.